How this company measures up on the fundamentals that matter
FactSet Research Systems Inc., together with its subsidiaries, operates as a financial digital platform and enterprise solutions provider for the investment community. It offers data, products, and analytical applications; and workstations, portfolio analytics, and enterprise data solutions, as well as managed services for supporting data, performance, risk, and reporting workflows. The company also provides subscription-based financial data and market intelligence on securities, companies, industries, and people that enable clients to research investment ideas, as well as analyze, monitor, and manage portfolios; and solutions covering investment lifecycle of investment research, portfolio construction and analysis, trade execution, performance measurement, risk management, and reporting. In addition, it offers services through configurable desktop and mobile platform, data feeds, cloud-based digital solutions, and application programming interfaces. It operates in Europe, the Middle East, Africa, the Americas, the Asia Pacific, and internationally. The company serves investment professionals, including institutional asset managers, bankers, wealth managers, asset owners, partners, hedge funds, corporate users, and private equity and venture capital professionals. FactSet Research Systems Inc. was founded in 1978 and is headquartered in Norwalk, Connecticut.
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Trading at $224 against a fair value of $388, a 42% discount. Strong competitive moat. Fails ethical screen (Business activity screen). Ranks better than 83% of screened stocks.
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
Trading characteristics and market positioning
Balance sheet strength and cash generation — the foundation of long-term value
SEC Form 4 filings — what company insiders are buying and selling
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-01 | WARREN JOSHUA | Chief Financial Officer | 2,272 | — | |
| 2026-01-15 | FRANK MALCOLM | Director | 713 | — | |
| 2026-01-15 | ABRAMS ROBIN ANN | Director | 604 | — | |
| 2026-01-15 | HYLTON LAURIE G | Director | 439 | — | |
| 2026-01-15 | SIEGEL LAURIE A | Director | 626 | — | |
| 2026-01-15 | SHAVEL LEE M | Director | 571 | — | |
| 2026-01-15 | EILAM BARAK | Director | 439 | — | |
| 2026-01-15 | CHOY SIEW KAI | Director | 439 | — | |
| 2026-01-15 | TEJADA MARIA TERESA | Director | 439 | — | |
| 2026-01-15 | WIESEL SHLOMO ELISHA | Director | 571 | — |
Congressional trading disclosures involving this instrument
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-04-13 | Ro Khanna | Democrat | Purchase | 1K–15K |
Data sourced from public filings and market feeds. Not financial advice. Updated: